VVT Med Inc.
Research VVT Med Inc. (VVTM) on Bullrun: market cap CAD 14.08M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVVTM
- ExchangeV
- CountryIsrael
- SectorHealthcare
- IndustryMedical Devices
- CurrencyCAD
- Market capCAD 14.08M
- Financial periodQ1 2026
- RevenueUSD 54.00K
- Net income-USD 557.00K
- Free cash flow-USD 68.00K
- Gross margin66.7%
Valuation Snapshot
latest market cap is CAD 14.08M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 89.00K | -USD 3.98M | -USD 3.17M | 70.8% | n/a | USD 145.00K | USD 1.06M | -USD 1.82M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | CAD 14.08M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is VVT Med Inc.'s market cap?
VVT Med Inc.'s market capitalization is CAD 14.08M.
What does VVT Med Inc. do?
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.